Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for NDA 213218

Expand all

SOAANZ (TORSEMIDE)
40MG
Marketing Status: Prescription

Active Ingredient: TORSEMIDE
Proprietary Name: SOAANZ
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 40MG
Reference Listed Drug: Yes
Reference Standard: No
TE Code: 
Application Number: N213218
Product Number: 003
Approval Date: Nov 17, 2021
Applicant Holder Full Name: SARFEZ PHARMACEUTICALS INC
Marketing Status:  Prescription
Patent and Exclusivity Information

SOAANZ (TORSEMIDE)
20MG
Marketing Status: Discontinued

Active Ingredient: TORSEMIDE
Proprietary Name: SOAANZ
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 20MG
Reference Listed Drug: Yes
Reference Standard: No
TE Code: 
Application Number: N213218
Product Number: 001
Approval Date: Jun 14, 2021
Applicant Holder Full Name: SARFEZ PHARMACEUTICALS INC
Marketing Status:  Discontinued
Patent and Exclusivity Information

SOAANZ (TORSEMIDE)
60MG
Marketing Status: Discontinued

Active Ingredient: TORSEMIDE
Proprietary Name: SOAANZ
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 60MG
Reference Listed Drug: Yes
Reference Standard: No
TE Code: 
Application Number: N213218
Product Number: 002
Approval Date: Jun 14, 2021
Applicant Holder Full Name: SARFEZ PHARMACEUTICALS INC
Marketing Status:  Discontinued
Patent and Exclusivity Information